FIELD: pharmacy.
SUBSTANCE: invention relates to pharmaceutical compositions in the form of cellular mechanically stable, lamellar, porous, spongy or foam-like structures and to a method for their preparing from solutions and dispersions. Method involves carrying out the following stages: a) preparing a solution or homogenous dispersion liquid and compound taken among the group including one or some pharmaceutically active compounds, one or some pharmaceutically acceptable additives and their mixtures, and the following stage b) foaming solution or homogenous dispersion at reducing pressure 30-150 torrs without boiling. Invention provides stabilizing the composition.
EFFECT: improved preparing method.
38 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND SUCROSE FATTY ACID ESTER | 2002 |
|
RU2271808C2 |
DISPERSION COMPOSITION CONTAINING LIPASE INHIBITORS | 2000 |
|
RU2239428C2 |
SOLID LIPID COMPOSITIONS | 2000 |
|
RU2248218C2 |
NOVEL PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2241462C2 |
PHARMACEUTICAL COMPOSITION CONTAINING LIPASE INHIBITOR AND GLUCOMANNAN | 2003 |
|
RU2297221C2 |
PHARMACEUTICAL COMPOSITION WITH HIGH STABILITY AND SOLUBILITY AND PRODUCTION PROCESS | 2006 |
|
RU2409362C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2589842C2 |
COMPOSITION AND DOSAGE FORM CONTAINING SOLID OR SEMISOLID MATRIX | 2006 |
|
RU2423997C9 |
PHARMACEUTICAL COMBINATION AND COMPOSITION FOR TREATING OBESITY AND USE THEREOF | 2011 |
|
RU2608928C2 |
OPHTHALMIC COMPOSITION | 2012 |
|
RU2639472C2 |
Authors
Dates
2005-01-20—Published
2001-06-18—Filed